Join to View Full Profile
5323 Harry Hines BlvdDallas, TX 75390
Phone+1 214-645-0624
Fax+1 214-645-0078
Dr. Pan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Neuro-Oncology, 2000 - 2003
Tufts Medical CenterResidency, Neurology, 1997 - 2000
Cambridge Health AllianceInternship, Transitional Year, 1996 - 1997
Boston University School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 2000 - Present
TX State Medical License 2013 - 2027
FL State Medical License 2003 - 2014
United Council for Neurologic SubspecialtiesNeuro-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) Start of enrollment: 2013 May 06
- BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM) Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsPost-Traumatic Gliomas in Adults: Review of the Case Reports and Studies.Morgan Heinzelmann, Edward Pan
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 2023-05-01 - 28 citationsAn International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort.Sonja E Leonhard, Annemiek A van der Eijk, Henning Andersen, Giovanni Antonini, Samuel Arends
Neurology. 2022-09-20 - 16 citationsEGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation.Gao Guo, Ke Gong, Nicole Beckley, Yue Zhang, Xiaoyao Yang
Nature Cell Biology. 2022-08-01
Press Mentions
Team Engineers New Way to Get Medication Past Blood-Brain BarrierNovember 12th, 2021- An Adult Patient with Rare Primary Intracranial Alveolar RhabdomyosarcomaMarch 25th, 2019
Professional Memberships
- Member
- Member
- Society for Neuro-OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
